December 3, 2018 / 6:16 AM / 11 days ago

BRIEF-Polyphor Announces Positive Results From FDA Type B Guidance Meeting

Dec 3 (Reuters) - Polyphor AG:

* EQS-ADHOC: POLYPHOR ANNOUNCES POSITIVE RESULTS FROM THE FDA TYPE B GUIDANCE MEETING ON THE PLANNED PHASE III STUDY FOR BALIXAFORTIDE

* EXPECTS TO ENROLL FIRST PATIENT IN Q2 OF 2019 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below